Ona Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Barcelona
Business model:
B2B
Investors:
we tracked 4 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Ona Therapeutics develops a new drug aimed at blocking CD36 and inhibiting metastasis-forming cells. This therapeutic approach could prevent metastasis formation and remove existing, potentially any type of cancer.

Companies with similar profile to Ona Therapeutics:

CompanyCriteria
Spain Sanifit Therapeutics
76%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Alta Life Sciences | FCR
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Anaconda Biomed
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Asabys Partners
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oncomatryx
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Bigfinite
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Asarina Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark STipe Therapeutics
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Trialbee
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Galecto Biotech
53%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Ysios Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Spain Inbrain Neuroelectronics
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Asabys Partners, Alta Life Sciences | FCR
  • Minim one investor from outside Scandinavia: Yes
Spain Accure Therapeutics
45%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Alta Life Sciences | FCR
  • Minim one investor from outside Scandinavia: Yes
Spain Psious
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Asabys Partners
  • Minim one investor from outside Scandinavia: Yes
Denmark Octarine Bio
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland Nanoform Finland
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark Cirqle Biomedical
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway Vaccibody
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD